Which finding should prompt withholding lamotrigine due to a serious reaction?

Which finding should prompt withholding lamotrigine due to a serious reaction?

• A. Dizziness
• B. Nausea
• C. Headache
• D. Skin rash

Answer: (D)

Developing a skin rash while on lamotrigine is the red-flag warning for a potentially life-threatening reaction. Lamotrigine carries a risk of a serious hypersensitivity rash, including Stevens-Johnson syndrome, which can progress rapidly and involve mucous membranes. Because of this, any new rash prompts withholding the medication and urgent assessment, especially early in therapy when the dose is being titrated. If the rash is accompanied by fever, malaise, sore throat, or mucosal involvement, the situation is urgent and requires immediate medical evaluation. Dizziness, nausea, and headache are common, nonspecific side effects and, by themselves, do not signal a dangerous reaction requiring stopping treatment. They may be managed with supportive care or dose adjustments, but they do not carry the same level of risk as a new skin rash related to lamotrigine. The emphasis here is on promptly recognizing and halting therapy at the first sign of a rash to prevent progression to a severe illness.

Developing a skin rash while on lamotrigine is the red-flag warning for a potentially life-threatening reaction. Lamotrigine carries a risk of a serious hypersensitivity rash, including Stevens-Johnson syndrome, which can progress rapidly and involve mucous membranes. Because of this, any new rash prompts withholding the medication and urgent assessment, especially early in therapy when the dose is being titrated. If the rash is accompanied by fever, malaise, sore throat, or mucosal involvement, the situation is urgent and requires immediate medical evaluation.

Dizziness, nausea, and headache are common, nonspecific side effects and, by themselves, do not signal a dangerous reaction requiring stopping treatment. They may be managed with supportive care or dose adjustments, but they do not carry the same level of risk as a new skin rash related to lamotrigine. The emphasis here is on promptly recognizing and halting therapy at the first sign of a rash to prevent progression to a severe illness.